62 related articles for article (PubMed ID: 33724652)
1. Integrated analysis of the role of PR/SET domain 14 in gastric cancer.
Li X; Wang C; Wang Y; Chen X; Li Z; Wang J; Liu Y
BMC Cancer; 2024 Jun; 24(1):685. PubMed ID: 38840106
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications and mechanism of CST1 in gastric carcinoma based on database screening.
Liu P; Luan J; Peng X; Zhang X; Zhang J; Chang H
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):184-189. PubMed ID: 38814219
[TBL] [Abstract][Full Text] [Related]
3. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract][Full Text] [Related]
4. Distinct prognostic values and antitumor effects of tumor growth factor β1 and its receptors in gastric cancer.
Liu F; Wang H; Zhang M
Oncol Lett; 2020 Sep; 20(3):2621-2632. PubMed ID: 32782580
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation.
Xie N; Pan Y; Wu J; Bai Y; Xiao C; Gao X; Wang J; Liu N
Onco Targets Ther; 2021; 14():2541-2553. PubMed ID: 33880033
[TBL] [Abstract][Full Text] [Related]
6. Identification of SRGAP2 as a potential oncogene and a prognostic biomarker in hepatocellular carcinoma.
Li Y; Qiao L; Bai Y; Xiao C; Wu J; Gao X; Qiao C; Shi Y; Hou W; Wang J; Xie N; Liu N
Life Sci; 2021 Jul; 277():119592. PubMed ID: 33984363
[TBL] [Abstract][Full Text] [Related]
7. Effect of Extracellular Matrix Stiffness on Candesartan Efficacy in Anti-Fibrosis and Antioxidation.
Zhu T; Song J; Gao B; Zhang J; Li Y; Ye Z; Zhao Y; Guo X; Xu F; Li F
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978927
[TBL] [Abstract][Full Text] [Related]
8. ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.
Kanai R; Uehara T; Yoshizawa T; Kamakura M; Nakajima T; Kinugawa Y; Iwaya M; Asaka S; Kitazawa M; Nagaya T; Ota H
BMC Cancer; 2023 May; 23(1):478. PubMed ID: 37237373
[TBL] [Abstract][Full Text] [Related]
9. Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients.
Shang F; Wang Y; Shi Z; Deng Z; Ma J
Mol Biotechnol; 2023 Nov; 65(11):1796-1808. PubMed ID: 36790659
[TBL] [Abstract][Full Text] [Related]
10. The Effects of circ_000558/miR-1225-5p/ARL4C on Regulating the Proliferation of Renal Cell Carcinoma Cells.
Xia L; Ge M; Shan G; Qian H; Xia Y
J Oncol; 2023; 2023():1303748. PubMed ID: 36778920
[TBL] [Abstract][Full Text] [Related]
11. ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members.
Xie N; Shu Q; Wang Z; Huang X; Wang Y; Qin B; Chen Y; Liu N; Dong L; Wu J; Song Y
PLoS One; 2022; 17(11):e0274757. PubMed ID: 36367890
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer.
Kang D; Kim IH
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740397
[TBL] [Abstract][Full Text] [Related]
13. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
[TBL] [Abstract][Full Text] [Related]
14. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
16. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer.
Ge S; Zhang H; Deng T; Sun W; Ning T; Fan Q; Wang Y; Wang X; Zhang Q; Zhou Z; Yang H; Ying G; Ba Y
Invest New Drugs; 2019 Oct; 37(5):923-934. PubMed ID: 30607520
[TBL] [Abstract][Full Text] [Related]
17. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
18. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.
Xie N; Bai Y; Qiao L; Bai Y; Wu J; Li Y; Jiang M; Xu B; Ni Z; Yuan T; Shi Y; Wu K; Xu F; Wang J; Dong L; Liu N
J Cell Mol Med; 2021 Apr; 25(8):4014-4027. PubMed ID: 33724652
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
